Skip to main content
Watch Insiders

Corporate insider profile

Kevin Tang Insider Trades

Latest reported as 10% Owner of Boundless Bio, Inc. (BOLD).

Purchase filings
11
Reported companies
3
Net open-market value
$15,802,923
Latest transaction
Oct 26, 2026

Affiliated corporations

Reported company relationships

BOLDLatest reported

Boundless Bio, Inc.

10% Owner

FULCPrior filing

Fulcrum Therapeutics, Inc.

10% Owner

AUPHPrior filing

Aurinia Pharmaceuticals Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 26, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase21,640$2.39$51,620
Oct 20, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase149,474$2.34$349,590
Aug 26, 2026Boundless Bio, Inc. (BOLD)10% OwnerSale18,300$2.97$54,351
Jul 21, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase4,863$2.44$11,866
Jul 17, 2026Fulcrum Therapeutics, Inc. (FULC)10% OwnerOpen Market Purchase167,616$3.55$594,668
Jul 16, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase63,969$2.43$155,643
Jul 15, 2026Fulcrum Therapeutics, Inc. (FULC)10% OwnerOpen Market Purchase249,946$3.57$891,057
Jul 13, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase91,585$2.42$222,066
Jul 8, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase57,210$2.48$141,864
Jul 2, 2026Boundless Bio, Inc. (BOLD)10% OwnerOpen Market Purchase107,463$2.50$268,883
🔒 Create Free Insider Alerts — Join Watch Insiders